COLIN QUIGLEY: Open Payments
NPI 1689943920 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,479 in 16 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $22 · 2025 $1,479
Consulting: $920Food & beverage: $532Travel & lodging: $27
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $1,117 |
| ABBVIE INC. | 6 | $227 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Ipsen Biopharmaceuticals, Inc | 2 | $40 |
| QOL Medical, LLC | 1 | $26 |
| Intercept Pharmaceuticals, Inc. | 1 | $22 |
Products named: Livdelzi, SKYRIZI, MAVYRET, IQIRVO, GATTEX, Sucraid, OCALIVA, EOHILIA.
Industry payments across OH — which companies pay providers there.
